Dr. George C. Cheng, MD

Dr. Cheng practices at Sansum Clinic Pueblo Multi-Specialty Clinic in Santa Barbara, California.

Dr. Cheng's NPI, 1750437745, was assigned on January 25, 2007. Dr. Cheng graduated from Harvard Medical School in 1998. Dr. Cheng holds California license G87213.

Dr. Cheng's primary practice is Sansum Clinic Pueblo Multi-Specialty Clinic, at 540 W Pueblo St, Santa Barbara, CA 93105 in Santa Barbara County. The practice phone is (805) 681-1768.

Dr. Cheng's primary practice is Sansum Clinic Pueblo Multi-Specialty Clinic in Santa Barbara, California. Dr. Cheng is also affiliated with Santa Barbara Cottage Hospital. The medical group on file is Sansum Clinic. Dmand AI also links Dr. Cheng to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheng practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Cheng's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Cheng is board certified in radiation oncology by the American Board of Radiology. Dr. Cheng is licensed in California.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Cheng treats.

CMS data shows 5,863 Medicare services from Dr. Cheng across 28 procedure codes in 2024, for 433 Medicare patients. Medicare paid $1,175,469 for them.

CMS counts 433 Medicare patients who saw Dr. Cheng in 2024. The largest group is 75 to 84, with 183 patients. 73% of them have cancer, and 70% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheng's median patient age at 74, with 44% women.

In 2024, Dr. Cheng wrote 89 Medicare Part D claims for 45 patients. 89% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $294 in total drug cost. In 2023, CMS named 32 claims across 2 drugs.

Dr. Cheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheng as offering telehealth.

Dmand AI links 8 papers to Dr. Cheng. The most frequent topics are Cells, Cultured, Muscle, Smooth, Vascular and Fibroblast Growth Factor 2. Dr. Cheng has published most often in Circ Res. Dr. Cheng's most frequent co-authors are George Zhi Cheng, MD, PhD, Sebastian Fernandez-Bussy, MD and Erik Eduardo Folch, MD, MS.

CMS Open Payments shows 9 general payments to Dr. Cheng from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 96% of the total. Galvanize Therapeutics, Inc paid the most, $137.

Dmand AI lists 1 award for Dr. Cheng, most recently CMS Stage 1 EHR in 2013.

Dr. Cheng graduated from Harvard Medical School in 1998.

Dr. Cheng is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.